Mohamed, D., Kamel, A., Kherbetawy, M. (2024). Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma. Suez Canal University Medical Journal, 27(1), 65-72. doi: 10.21608/scumj.2024.343084
Dalia I. Mohamed; Amr A.M. Kamel; Mohamed K. E. Kherbetawy. "Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma". Suez Canal University Medical Journal, 27, 1, 2024, 65-72. doi: 10.21608/scumj.2024.343084
Mohamed, D., Kamel, A., Kherbetawy, M. (2024). 'Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma', Suez Canal University Medical Journal, 27(1), pp. 65-72. doi: 10.21608/scumj.2024.343084
Mohamed, D., Kamel, A., Kherbetawy, M. Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma. Suez Canal University Medical Journal, 2024; 27(1): 65-72. doi: 10.21608/scumj.2024.343084
Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
Department of Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Abstract
Background: SOX2 is a transcription factor involved in the self-renewal and pluripotency of embryonic stem cells (ESCs). It is involved in various cancer types and affects cancer cell physiology viainvolvement in complicated cell signaling and protein-protein interactions. im: Our work aimedto assess the expression patterns of SOX2 in prostatic adenocarcinoma in correlation with the histopathological findings to evaluate its role as a prognostic marker or possible therapeutic target. Materials and Methods: forty-eight specimens of prostatic adenocarcinoma were stained first H&E then immunohistochemically for SOX2 and scored by two histopathologists. Results: thirty-eight specimens showed positive nuclear expression of SOX2; with variable degrees. SOX2 expression showed a statistically significant association with different grade groups; with p-value = 0.025. There was no statistically significant association between its expression and the patient’s demographic data. Conclusion: Overexpression of SOX2 in Prostatic Adenocarcinoma could be an indicator of higher tumor grade and poor prognosis. It could be used as a prognostic biomarker for tumor aggressiveness.
View on SCiNiTO
Top